You are here

FDA’s New Approach to the Opioid Crisis

The Lancet

February 11, 2016 Print

The Lancet

FDA Confronts Opioid Addiction and Overdose Deaths

“There’s no one answer to this crisis. Attacking it on multiple fronts is important” – Roger D. Weiss, MD, chief of McLean’s Division of Alcohol and Drug Abuse

Download PDF